EPIL II definition

EPIL II means Elan Pharmaceuticals Investment II, Ltd. an exempted limited liability company incorporated under the laws of Bermuda.
EPIL II means Elan Pharmaceuticals Investment II, Ltd. an exempted limited liability company incorporated under the laws of Bermuda, a qualified special purpose entity of Elan Corp.
EPIL II means Elan Pharmaceuticals Investments II, Ltd. an exempted limited liability company incorporated under the laws of Bermuda. "EUR/(euro)" shall mean the lawful currency of Ireland.

Examples of EPIL II in a sentence

  • Neither the Company nor the Guarantor will, directly or indirectly, at any time any Existing EPIL Indebtedness is outstanding, without the prior written consent of the Required Existing EPIL Holders, amend, supplement or otherwise modify the Elan Funding Agreement; provided, however, that the Company and the Guarantor may amend, modify or supplement the Elan Funding Agreement to make any change that does not adversely affect the interests of the holders of the EPIL II Notes or the EPIL III Notes.

  • The Parties hereto acknowledge and agree that none of Elan Corp, EIS, EPIL II or their respective affiliates, subsidiaries, successors or assigns are obligated to purchase additional securities of or from Acorda, or their respective affiliates or subsidiaries, successors or assigns.

  • Neither the Company nor the Guarantor will, directly or indirectly, at any time any Existing EPIL Indebtedness is outstanding, without the prior written consent of the Required Existing EPIL Holders, amend, supplement or otherwise modify the Guarantor Intercompany Note; provided, however, that the Company and the Guarantor may amend, modify or supplement the Guarantor Intercompany Note to make any change that does not adversely affect the interests of the holders of the EPIL II Notes or the EPIL III Notes.

  • In 2006, the company repurchased 167,950 (2005 – 5,967,918) Class A common shares at a cost of $8 million (2005 – $162 million).

  • The EPIL II Notes were guaranteed on a subordinated basis by Elan and, consequently, in accordance with FRS 5 “Reporting the Substance of Transactions” (“FRS 5”), the EPIL II Notes and the investments were both included separately in the our Consolidated Balance Sheet.

  • These assets were not available for distribution outside EPIL II.

  • The investments held by EPIL II will be sold to meet the maturity of the loan notes.

  • Each Party acknowledges and agrees that EPIL II shall be deemed in all respects to be a third party beneficiary of the agreements contained in this Schedule 6.1 with the same force and effect as if EPIL II were a party thereto with regard to any securities of DOV or its Affiliates to which EPIL II is the holder of record.

  • Each Party acknowledges and agrees that EPIL II shall be deemed in all respects to be a third party beneficiary of the agreements contained in Clause 2.2 of the Agreement or in this Schedule 5.1, with the same force and effect as if EPIL II were a party thereto.

  • In June 2000, pursuant to an asset transfer agreement and certain related agreements, entered into on 28 June, 2000, by Elan and EPIL II, Elan transferred a portfolio of equity and debt securities to EPIL II.

Related to EPIL II

  • DS Electric generation service that is provided at retail pursuant to the Applicable Legal Authorities under the Company’s retail electric tariffs and under any other agreements or arrangements between the Company and Customers, to any Customer that is not being served by an EGS. Default Allocation Assessment – shall have the meaning ascribed to it under the PJM Agreements. Delivery Period – The delivery period specified in an Appendix C Transaction Confirmation. Delivery Point – Means the applicable zone of the Company as designated by PJM. DS Customer(s) – Retail customers who are provided Default Service pursuant to the terms of this Agreement, the Applicable Legal Authorities and the Company’s retail tariffs.

  • Qualified high-technology business means a business that is either of the following:

  • After-Acquired Intellectual Property has the meaning assigned to such term in Section 4.02(d).

  • Modern biotechnology means the application of:

  • Commercial Software means Software developed or regularly used that: (i) has been sold, leased, or licensed to the general public; (ii) has been offered for sale, lease, or license to the general public; (iii) has not been offered, sold, leased, or licensed to the public but will be available for commercial sale, lease, or license in time to satisfy the delivery requirements of this Contract; or (iv) satisfies a criterion expressed in (i), (ii), or (iii) above and would require only minor modifications to meet the requirements of this Contract.

  • Radiologic technologist, limited means an individual, other than a licensed radiologic technologist,

  • Technology means any and all technical information, specifications, drawings, records, documentation, works of authorship or other creative works, ideas, algorithms, models, databases, ciphers/keys, systems architecture, network protocols, research, development, and manufacturing information, software (including object code and source code), application programming interfaces (APIs), innovations, mask works, logic designs, circuit designs, technical data, processes and methods.

  • Soil texture means proportion by weight of sand, silt, and clay in a soil.

  • Alliance means the Public Service Alliance of Canada;

  • Alternative energy technology means equipment, component parts, materials, electronic devices, testing equipment, and related systems that are specifically designed, specifically fabricated, and used primarily for 1 or more of the following:

  • Nursing home-type patients means a patient who has been in hospital more than 35 days, no longer requires acute hospital care, cannot live independently at home or be looked after at home, and either cannot be placed in a nursing home or a nursing home place is not available.

  • AMI means Area Median Income as defined by HUD.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Non-Participating Home Infusion Therapy Provider means a Home Infusion Therapy Provider who does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.